Expression of NF2-encoded merlin and related ERM family proteins in the human central nervous system

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 6, 1997, Pages 735-742

  Stemmer Rachamimov, Anat O ^a   Gonzalez Agosti, Charo ^a   Xu, Lin ^a   Burwick, Jennifer A ^a   Beauchamp, Roberta ^a   Pinney, Denise ^a   Louis, David N ^a   Ramesh, Vijaya ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Ezrin; Glia; Merlin; Moesin; Neurofibromatosis 2; NF2; Radixin

Indexed keywords

CYTOSKELETON PROTEIN; EZRIN; MERLIN; MOESIN; RADIXIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTROCYTE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; GLIA CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030782724     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199706000-00011     Document Type: Article

References (32)

1. Louis DN, Ramesh V, Gusella JF. Neuropathology and molecular genetics of neurofibromatosis 2 and related tumors. Brain Pathol 1995;5:163-72
2. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993;72:791-800
3. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993;363:515-21
4. Turunen O, Wahlstrom T, Vaheri A. Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol 1994;126:1445-53
5. Claudio OJ, Lutchman M, Rouleau GA. Widespread but cell type-specific expression of the mouse neurofibromatosis type 2 gene. NeuroReport 1995;6:1942-46
6. den Bakker MA, Tascilar M, Riegman PHJ, et al. Neurofibromatosis type 2 protein co-localizes with elements of the cytoskeleton. Am J Pathol 1995;147:1339-49
7. Gonzalez-Agosti C, Xu L, Pinney D, et al. The merlin tumor suppressor localizes preferntially in membrane ruffles. Oncogene 1996;13:1239-47
8. Bohling T, Turunen O, Jaaskelainen J, et al. Ezrin expression in stromal cells of capillary hemangioblastoma. Am J Pathol 1996;367-73
9. Winckler B, Gonzalez-Agosti C, Magendantz M, Solomon F. Analysis of a cortical cytoskeletal structure: A role for ezrin-radixin-moesin (ERM proteins) in the marginal band of chicken erythrocytes. J Cell Sci 1994;107:2523-34
10. Laemmli U. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-85
11. McCartney BM, Fehon RG. Distinct cellular and subcellular patterns of expression imply functions for the Drosophila homologues of moesin and the NF2 tumor-suppressor merlin. J Cell Biol 1996;133:843-52
12. Daston M, Scrable H, Nordlund M, Sturbaum A, Nissen L, Ratner N. The protein product of the neurofibromatosis type 1 gene is expressed in highest abundance in neurons, Schwann cells, and oligodendrocyes. Neuron 1992;8:415-28
13. Los M, Jansen G, Kaelin W, Lips C, Blijham G, Voest E. Expression pattern of the von Hippel-Lindau protein in human tissues. Lab Invest 1996;75:231-38
14. Kerfoot C, Wienecke R, Menchine M, et al. Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis. Brain Pathology 1996;6:367-75
15. Wiestler O, von Siebental K, Schmitt H, Feiden W, Kleihues P. Distribution and immunoreactivity of cerebral micro-hamartomas in bilateral acoustic neurofibromatosis (neurofibromatosis 2). Acta Neuropathol 1989;79:137-43
16. Bretscher A. Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor. J Cell Biol 1989;108:921-30
17. Blanchi AB, Mitsunaga S-I, Cheng JQ, et al. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci USA 1995;92:10854-58
18. Bianchi AB, Tetsuo H, Ramesh V, et al. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nature Genet 1994;6:185-92
19. Martuza RL, Eldridge R. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). New Eng J Med 1988;318:684-88
20. Rodriguez FJL, Geiger B, Salomon D, Sabanay I. Suppression of tumorigenicity in transformed cells after transfection with vinculin cDNA. J Cell Biol 1992;119:427-38
21. Gusella J, Ramesh V, MacCollin M, Jacoby L. NF2: Loss of merlin's protective spell. Curr Opp Genet Develop 1996;6:87-92
22. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 1994;3:347-50
23. Tikoo A, Varga M, Ramesh V, Gusella J, Martua H. An anti-Ras function of the neurofibromatosis type 2 gene product (NF2/Merlin). J Biol Chem 1994;269:23387-90
24. Luna EJ, Litt AL. Cytoskeleton-plasma membrane interactions. Science 1992;258:955-56
25. Lankes WT, Furthmayr H. Moesin: A member of the protein 4.1-talin-ezrin family of proteins. Proc Natl Acad Sci USA 1991;88: 8297-8301
26. Furthmayr H, Lankes W, Amieva M. Moesin, a new cytoskeletal protein and constituent of filopodia: Its role in cellular functions. Kidney Int 1992;41:665-70
27. Goslin K, Birgbauer E, Banker G, Solomon F. The role of cytoskeleton in organizing growth cones; a microfilament-associated growth cone component depends upon microtubules for its localization. J Cell Biol 1989;109:1621-31
28. Bretscher A. Purification of an 80,000-dalton protein that is a component of the isolated microvillus cytoskeleton, and its localization in nonmuscle cells. J Cell Biol 1983;97:425-32
29. Henry M, Gonzalez-Agosti C, Solomon F. Molecular dissection of radixin: Distinct and interdependent functions of the amino and carboxy terminal domains. J Cell Biol 1995;129:1007-22
30. Tsukita S, Hieda Y, Tsukita S. The new 82-kD end-capping protein (radixin) localized in the cell to cell adherens junction: Purification and characterization. J Cell Biol 1989;108:2369-82
31. Tsukita S, Oishi K, Sato N, Sagara J, Kawai A, Tsukita S. ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons. J Cell Biol 1994;126:391-401
32. Wells A, Welsh J, Lazar C, Wiley H, Gill G, Rosenfeld M. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science 1990;247:962-65